GPT Healthcare IPO: The Initial Public Offering (IPO) of GPT Healthcare Ltd., which is well-known for its network of mid-sized full-service hospitals under the “ILS Hospitals” brand, is scheduled to go live today, Thursday, February 22.
The initial public offering (IPO), which has a face value of Rs 10 and an equity share price range of Rs 177 to Rs 186, is being watched carefully as it goes public. There are multiples available in increments of 80 equity shares, with the lot size for the GPT Healthcare IPO being fixed at 80 equity shares.
The shares are trading at the issue price of Rs 186, with no premium or discount, according to Investorgain.com, which reports a Grey Market Premium (GMP) of zero. On Wednesday, February 21, the allocation to anchor investors is planned.
A fresh issue of Rs 40 crore and an offer-for-sale (OFS) of 26,082,786 equity shares at a price of Rs 10 each make up the Rs 525.14 crore valuation of the GPT Healthcare IPO. Through the OFS, the investor-selling shareholder, BanyanTree Growth Capital II, LLC, hopes to raise up to Rs 485.14 crore.
The company’s overall goals and the repayment of any outstanding bank and financial institution loans, in full or in part, will be funded by the net proceeds from the initial public offering.
A minimum of 15% of the shares are reserved for Non-Institutional Investors (NII), at least 35% are reserved for retail investors, and no more than 50% of the shares are reserved for Qualified Institutional Buyers (QIB).
On Tuesday, February 27, the basis of allotment for the shares of the GPT Healthcare IPO is anticipated to be finalized. On Wednesday, February 28, refunds are scheduled to start, and the same day, shares will be credited to demat accounts. Thursday, February 29 is the tentative date for the listing on the BSE and NSE.
The GPT Healthcare IPO’s book-running lead manager is JM Financial Limited, and its registrar is Link Intime India Private Ltd.
